Stuelpnagel John R 的 Form 4 申報
10x Genomics, Inc.（TXG），2021/11/3 申報
- 申報編號
- 0001567619-21-019298
- 申報時間
- 2021/11/3
- 交易日
- 2021/11/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $81.8 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Stuelpnagel John RCIK 0001189140 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/1 | Class A Common Stock | S賣出處分 | −100 | $160.33 | −$16,033 | 361,516 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −100 | $160.75 | −$16,075 | 361,416 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −100 | $161.52 | −$16,152 | 361,316 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −1,494 | $163.10F2 | −$243,671.4 | 359,822 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −2,906 | $163.89F3 | −$476,264.34 | 356,916 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −300 | $164.58F4 | −$49,374 | 356,616 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $162.50 to $163.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $163.50 to $164.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $164.55 to $164.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。